Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
Clinical trial NCT03207945 · COMPLETED
Trial details
- NCT number
- NCT03207945
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-30
- Primary completion
- 2025-08-24
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.